Home/Filings/4/0001439222-22-000030
4//SEC Filing

Car Bruce 4

Accession 0001439222-22-000030

CIK 0001439222other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:11 PM ET

Size

7.8 KB

Accession

0001439222-22-000030

Insider Transaction Report

Form 4
Period: 2022-03-01
Car Bruce
Chief Scientific Officer
Transactions
  • Award

    Restricted stock units

    2022-03-01+11,50011,500 total
    Common stock (11,500 underlying)
  • Award

    Stock options (right to buy)

    2022-03-01+41,00041,000 total
    Exercise: $32.20Exp: 2032-03-01Common stock (41,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
  • [F3]This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Issuer

AGIOS PHARMACEUTICALS, INC.

CIK 0001439222

Entity typeother

Related Parties

1
  • filerCIK 0001798876

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:11 PM ET
Size
7.8 KB